SUSRF OTC
Surgical Science Sweden AB
1W: +0.0%
1M: +0.0%
3M: +30.0%
YTD: +52.5%
1Y: -46.5%
3Y: -67.8%
$5.20
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$4.7B
-14.6% ▼
5Y CAGR: +58.2%
Total Liabilities
$417M
-35.9% ▼
5Y CAGR: +56.0%
Shareholders Equity
$4.3B
-11.7% ▼
5Y CAGR: +58.4%
Cash & Investments
$615M
-36.5% ▼
5Y CAGR: +47.8%
Total Debt
$2M
-97.2% ▼
5Y CAGR: -6.9%
Net Debt
-$613M
+16.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $317M | $434M | $634M | $968M | $615M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $317M | $434M | $634M | $968M | $615M |
| Net Receivables | $180M | $244M | $111M | $278M | $208M |
| Inventory | $113M | $135M | $154M | $180M | $205M |
| Other Current Assets | $69M | $68M | $81M | $1K | $9 |
| Total Current Assets | $617M | $826M | $991M | $1.4B | $1.2B |
| Property, Plant & Equip. | $38M | $51M | $77M | $102M | $106M |
| Goodwill & Intangibles | $3.3B | $3.7B | $3.6B | $3.9B | $3.4B |
| Long-Term Investments | $5M | $4M | $5M | $0 | $9M |
| Other Non-Current Assets | -$2K | -$2K | $15M | $8M | -$22M |
| Total Non-Current Assets | $3.4B | $3.8B | $3.7B | $4.1B | $3.5B |
| Total Assets | $4.0B | $4.6B | $4.7B | $5.5B | $4.7B |
| — Liabilities — | |||||
| Accounts Payable | $34M | $66M | $41M | $58M | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $17M | $71M | $73M | $0 | $0 |
| Other Current Liabilities | $77M | $125M | $73M | $454M | $290M |
| Total Current Liabilities | $232M | $306M | $235M | $513M | $290M |
| Long-Term Debt | $0 | $0 | $0 | $235M | $2M |
| Other Non-Current Liab. | $100M | $41M | $62M | -$198M | $125M |
| Total Non-Current Liabilities | $161M | $107M | $123M | $138M | $127M |
| Total Liabilities | $393M | $413M | $357M | $651M | $417M |
| — Equity — | |||||
| Common Stock | $3M | $3M | $3M | $3M | $3M |
| Retained Earnings | $86M | $274M | $508M | $639M | $704M |
| Accumulated OCI | $118M | $581M | $0 | $0 | $0 |
| Total Stockholders Equity | $3.6B | $4.2B | $4.3B | $4.8B | $4.3B |
| Total Liabilities & Equity | $4.0B | $4.6B | $4.7B | $5.5B | $4.7B |
| — Key Metrics — | |||||
| Total Debt | $12M | $15M | $40M | $57M | $2M |
| Net Debt | -$305M | -$419M | -$594M | -$733M | -$613M |
| Total Investments | $5M | $4M | $5M | $0 | $9M |